John Clarke > DLA Piper LLP (US) > New York, United States > Lawyer Profile
DLA Piper LLP (US) Offices
![DLA Piper LLP (US) company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/908.jpg?v=1653316305)
1251 6TH AVE,
NEW YORK, NY 10020-1104
NEW YORK
United States
- Firm Profile
- Go to...
John Clarke
![John Clarke photo](https://www.legal500.com/wp-content/uploads/sites/13/2020/07/john_clarke_Legal-500.jpg)
Work Department
Corporate; Litigation, Arbitration and Investigations; Mergers and Acquisitions; Financial Services; Life Sciences
Position
Partner; Co-Chair, Corporate and Securities Litigation Practice
Lawyer Rankings
United States > Dispute resolution > M&A litigation: defense
DLA Piper LLP (US) continues to forge a track record of success in M&A litigation, not least through its lead partners John Clarke in New York and head of Delaware litigation John Reed in Wilmington. The firm’s Delaware office increasingly puts it in pole position for high-stakes cases, a prime example being Reed’s work for MSG Networks in a post-closing action alleging breach of fiduciary duty by directors in approving the 2021 acquisition of the company by Madison Square Garden Entertainment Corp. The firm is frequently involved in mid-market transactions and consequent litigation, but it also plays a prominent role in many high-value matters, and Clarke’s work for Bristol-Myers Squibb in an action concerning its 2019 merger with Celgene Corporation is just one example. The firm is active across the US, with Melanie Walker in Los Angeles, Benjamin Schuman in Baltimore, and Jason Hopkins in Dallas all playing central roles in key matters.
United States > Dispute resolution > Securities litigation: defense
Clients praise DLA Piper LLP (US) for its ‘excellent subject matter expertise’. The firm is best known for its work on behalf of companies in the life sciences, financial services, insurance and technology sectors. The co-chairs of the practice, John Clarke in New York and Melanie Walker in Los Angeles, are highly respected for complex litigation and internal investigations involving securities and financial instruments. Experienced LA-based partner Richard Zelichov is ‘extremely diligent and very creative’. He recently assisted former officers of Workhorse with the resolution of a securities class and nine derivative suits concerning statements about its participation in the proposal process for a next generation delivery vehicle for the USPS. Seasoned trial and appellate lawyer John Hillebrecht in New York and former SEC attorney Jason Lewis in Dallas are also key members of the practice.
Lawyer Rankings
- M&A litigation: defense United States > Dispute resolution
- Securities litigation: defense United States > Dispute resolution
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > International tax
- Real estate > Land use/zoning
- Investment fund formation and management > Alternative/hedge funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- International trade > CFIUS
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Insurance > Advice to insurers
- Industry focus > Cannabis
- Dispute resolution > E-discovery
- Tax > Financial products
- Finance > Fintech
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Antitrust > Cartel
- Intellectual property > Copyright
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: litigation
- Dispute resolution > General commercial disputes
- Government > Government contracts
- Dispute resolution > International arbitration
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Project finance
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Transport > Rail and road: litigation and regulation
- International trade > CFIUS